What are the problems with using the peritoneal membrane for long-term dialysis?

Seminars in Dialysis

Volumn 21, Issue 1, 2008, Pages 11-13

  Bargman, Joanne M ^a   Krediet, Raymond T ^b   Lo, Wai Kei ^c   Selgas, Rafael ^d   Del Peso, Gloria ^d   Auxiliadora Bajo, M ^d   Mujais, Salim ^e  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c TUNG WAH HOSPITAL   (Hong Kong)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e Red Renal de Investigación Cooperativa ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID;

CHRONIC KIDNEY FAILURE; DYSLIPIDEMIA; FOLLOW UP; HUMAN; METABOLISM; METHODOLOGY; PERITONEAL DIALYSIS; PERITONEUM; PHYSIOLOGY; REVIEW; RISK FACTOR; TIME; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; DIALYSIS SOLUTIONS; DYSLIPIDEMIAS; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONEUM; RISK FACTORS; TIME FACTORS;

EID: 38749103888     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00385_1.x     Document Type: Review

References (145)

1. Bergstrom J, Furst P, Alvestrand A, Lindholm B : Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 44 : 1048 1057, 1993
2. Moberly JB, Mujais S, Gehr T, et al. : Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int 62 (Suppl. 81 S23 S33, 2002
3. Diaz-Buxo J : Is weight gain inevitable in most chronic peritoneal dialysis patients? Adv Perit Dial 8 : 334 339, 1992
4. Nolph KD, Sorkin M, Rubin J, et al. : Continuous ambulatory peritoneal dialysis: three-year experience at one center. Ann Intern Med 92 : 609 613, 1980
5. Williams PKR, Harrison J, et al. : Nutritional and anthropometric assessment of patients on CAPD over one year: Contrasting changes in total body nitrogen and potassium. Perit Dial Bull 1 : 82 87, 1981
6. Jolly S, Chatatalsingh C, Bargman J, Vas S, Chu M, Oreopoulos DG : Excessive weight gain during peritoneal dialysis. Int J Artif Organs 24 : 197 202, 2001
7. Armstrong VW, Creutzfeldt W, Ebert R, Fuchs C, Hilgers R, Scheler F : Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients. Nephron 39 : 141 145, 1985
8. Lameire NMD, Matthys E, et al. : Effects of long-term CAPD on carbohydrate and lipid metabolism. Clin Nephrol 30 (Suppl. 1 S53 S58, 1988
9. Woodward RS, Schnitzler MA, Baty J, et al. : Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 3 : 590 598, 2003
10. Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK : New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis 49 : 524 532, 2007
11. Attman PO, Alaupovic P : Lipid abnormalities in chronic renal insufficiency. Kidney Int 39 (Suppl. 31 S16 S23, 1991
12. Wheeler DC : Abnormalities of lipoprotein metabolism in CAPD patients. Kidney Int 50 (Suppl. 56 S41 S46, 1996
13. Wanner C, Bartens W, Walz G, Nauck M, Schollmeyer P : Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients. Nephrol Dial Transplant 10 : 75 81, 1995
14. Davies SJ, Bryan J, Phillips L, Russell GI : Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11 : 498 506, 1996
15. Wanner C, Krane V, Marz W, et al. : Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 : 238 248, 2005
16. Heimburger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B : Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38 : 495 506, 1990
17. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI : What really happens to people on long-term peritoneal dialysis? Kidney Int 54 : 2207 2217, 1998
18. Honda K, Nitta K, Horita S, et al. : Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 14 : 1541 1549, 1999
19. Williams JD, Craig KJ, Topley N, et al. : Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13 : 470 479, 2002
20. Hendriks PM, Ho-dac-Pannekeet MM, van Gulik TM, et al. : Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int 17 : 136 143, 1997
21. Davies SJ, Phillips L, Naish PF, Russell GI : Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12 : 1046 1051, 2001
22. Chung SH, Heimburger O, Stenvinkel P, Qureshi AR, Lindholm B : Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 18 : 590 597, 2003
23. Wang AY, Woo J, Wang M, et al. : Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 20 : 396 403, 2005
24. Twardowski ZJ, Nolph KD, Khanna R, Prowant B, Ryan LP, Moore HL, Nielsen MP : Peritoneal equilibration test. Perit Dial Bull 7 : 138 147, 1987
25. Davies SJ, Brown B, Bryan J, Russel GI : Clinical evaluation of the peritoneal equilibration test: a population-based study. Nephrol Dial Transplant 8 : 64 70, 1993
26. Wang T, Heimbürger O, Waniewski J, Bergström J, Lindholm B : Increased peritoneal permeability is associated with decreased small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 13 : 1242 1249, 1998
27. Wang T, Waniewski J, Heimbürger O, Werynski A, Lindholm B : A quantitative analysis of sodium transport and removal during peritoneal dialysis. Kidney Int 52 : 1609 1616, 1997
28. Wu C-H, Huang C-C, Huang J-Y, Wu M-S, Leu M-L : High flux peritoneal membrane is a risk factor in survival of CAPD treatment. Adv Perit Dial 12 : 105 109, 1996
29. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Pagé D, for the CANUSA Study Group : Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 9 : 1285 1292, 1998
30. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG : Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 17 : 2591 2598, 2006
31. Rumpsfeld M, McDonald SP, Johnson DW : Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 17 : 271 278, 2006
32. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, Divino Filho JC, Vonesh E, van Bree M : Survival of functionally anuric patients on automated peritoneal dialysis: The European APD Outcome Study. J Am Soc Nephrol 14 : 2948 2957, 2003
33. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, Duman N, Karatan O, Ertug AE : Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 60 : 767 776, 2001
34. Krediet RT, Lindholm B, Rippe B : Pathophysiology of peritoneal membrane failure. Perit Dial Int 20 (Suppl. 4 S22 S42, 2000
35. Numata M, Nakayama M, Nimura S, Kawakami M, Lindholm B, Kawaguchi Y : Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate. Perit Dial Int 23 : 116 122, 2003
36. Chung SH, Chu WS, Lee HA, Kim YH, Lee IS, Lindholm B, Lee HB : Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients. Perit Dial Int 20 : 541 547, 2000
37. Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW : Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis 43 : 492 501, 2004
38. Topley N, Williams JD : Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 46 (Suppl. 48 S71 S78, 1994
39. Selgas R, del Peso G, Bajo M-A, Castro M-L, Molina S, Cirugeda A, Sanchez-Tomero JA, Castro M-J, Alvarez V, Corbi A, Vara F : Spontaneous VEGF production by cultured mesothelial cells from patients on peritoneal dialysis. Perit Dial Int 20 : 798 801, 2000
40. Visser CE, Brouwer-Steenbergen JJE, Betjes MGH, Koomen GCM, Beelen RHJ, Krediet RT : Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 10 : 64 69, 1995
41. Ho-Dac-Pannekeet MM, Krediet RT : Inflammatory changes in vivo during CAPD. What can the effluent tell us? Kidney Int 50 (Suppl. 56 S12 S16, 1996
42. Krediet RT : Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 21 : 560 567, 2001
43. Davies SJ, Brian J, Phillips L, Russel GI : The predictive value of Kt/V and peritoneal solute transport in CAPD patients in dependent on the type of comorbidity present. Perit Dial Int 16 (Suppl. 1 S158 S162, 1990
44. Pecoits-Filho R, Araujo MRT, Lindholm B, Stenvinkel P, Abensur H, Romão JE Jr., Marcondes M, Freira de Oliveira AH, Noronha IL : Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 17 : 1480 1486, 2002
45. Pecoits-Filho R, Carvalho MJ, Stenvinkel P, Lindholm B, Heimburger O : Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis. Perit Dial Int 26 : 53 63, 2006
46. Rodrigues A, Martins M, Santos MJ, Fonseca I, Oliveira JC, Cabrita A, Castro e Melo J, Krediet RT : Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor and interleukin-6: relationship with peritoneal transport. Adv Perit Dial 20 : 8 12, 2004
47. Rodrigues AS, Martins M, Korevaar JC, Silva S, Oliveira JC, Cabrita A, Castro e Melo J, Krediet RT : Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters. Am J Nephrol 27 : 84 91, 2007
48. Van Esch S, Zweers MM, Jansen MAM, de Waart DR, van Manen JG, Krediet RT : Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients. Perit Dial Int 24 : 554 561, 2004
49. Lo W-K, Brendolan A, Prowant BF, Moore HL, Khanna R, Twardowski ZJ, Nolph KD : Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients. J Am Soc Nephrol 4 : 1466 1474, 1994
50. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT : Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 51 : 888 893, 1997
51. Krediet RT, Zuyderhoudt FMJ, Boeschoten EW, Arisz L : Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Invest 17 : 43 52, 1987
52. Douma CE, de Waart DR, Struijk DG, Krediet RT : Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? J Lab Clin Med 132 : 329 340, 1998
53. Smit W, van den Berg N, Schouten N, Aikens E, Struijk DG, Krediet RT : Free water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD. Kidney Int 65 : 298 303, 2004
54. Zemel D, Koomen GCM, Hart AAM, ten Berge RJM, Struijk DG, Krediet RT : Relationship of TNF-α, interleukin-6 and prostogladins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 122 : 686 696, 1993
55. Heimburger O, Waniewski J, Werynski A, Traneaus A, Lindholm B : Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38 : 495 506, 1990
56. Smit W, Schouten N, van den Berg N, Langedijk M, Struijk DG, Krediet RT, for the Netherlands Ultrafiltration Failure Study Group : Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross sectional study. Perit Dial Int 24 : 562 570, 2004
57. Honda K, Nitta K, Horita S, Yumura W, Nikei H : Morphological changes in the vasculature of patients on CAPD with ultrafiltration failure. Nephron 72 : 171 176, 1996
58. Mateijsen MAM, van der Wal AC, Hendriks PMEM, Zweers MM, Mulder JB, Struijk DG, Krediet RT : Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19 : 517 525, 1999
59. Williams JD, Craig KJ, Topley N, von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT, on behalf of the Peritoneal Biopsy Study Group : Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13 : 470 479, 2002
60. Davies SJ, Phillips L, Naish PF, Russel GI : Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12 : 1046 1051, 2001
61. Davies SJ : Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 66 : 2437 2445, 2004
62. Smit W, Struijk DG, Ho-dac-Pannekeet MM, Krediet RT : Quantifications of free water transport in peritoneal dialysis. Kidney Int 66 : 849 854, 2004
63. Parikova A, Smit W, Struijk DG, Krediet RT : Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. Kidney Int 70 : 1988 1994, 2006
64. Jansen MAM, Termorshuizen F, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT, for the NECOSAD Study Group : Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 68 : 1199 1205, 2005
65. van Olden RW, Guchelaar H-J, Struijk DG, Krediet RT, Arisz L : Acute effects of high dose furosemide on residual renal function in CAPD patients. Perit Dial Int 23 : 339 347, 2003
66. Medcalf JF, Harris KPG, Walls J : Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 59 : 1128 1133, 2001
67. Li PK-T, Chow K-M, Wong TY-H, Leung C-B, Szeto C-C : Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis; a randomized controlled study. Ann Intern Med 139 : 105 112, 2003
68. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J, on behalf of the Euro-Balance Trial Group : The Euro-Balance Trial; the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 66 : 408 418, 2004
69. Davies S, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, Bosselmann H-P, Heimburger O, Simonson O, Davenport A, Traneaus A, Divino-Filho JC : Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 14 : 1338 2344, 2003
70. Konings CJAM, Koomen JP, Schonck M, Gladziwa U, Wirtz J, Gerlag PG, Hoorntje SJ, Wolters J, van der Sande FM, Leunissen KML : Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 63 : 1556 1563, 2003
71. Hekking LH, Zareie M, Driesprong BA, Faict D, Welten AG, de Greeuw I, Schadee-Eestermans IL, Havenith CE, van den Born J, ter Wee PM, Beelen RH : Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol 12 : 2775 2786, 2001
72. Kolesnyk I, Dekker FW, Noordzij M, Le Cessie S, Struijk DG, Krediet RT : Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients. Perit Dial Int 27 : 446 453, 2007
73. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 48 (Suppl. 1 S99 S163, 2006
74. European Best Practice Guidelines for peritoneal dialysis. Nephrol Dial Transpl 20 (Suppl. 9 ix1 ix37, 2005
75. Lo WK, Bargman J, Burkart J, Krediet RT, Pollock C, Kawanishi H, Blake P : The International Society for Peritoneal Dialysis (ISPD) guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int 26 : 520 522, 2006
76. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. : Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13 : 1307 1320, 2002
77. Lo WK, Ho YW, Li CS, Chan TM, Wong KS, Yu AWY, et al. : Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomised prospective study. Kidney Int 64 : 649 656, 2003
78. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al. : Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 30 : 334 342, 1997
79. Heaf JG, Lokkegaard H, Madsen M : Initial survival advantage of peritoneal dialysis relative to hemodialysis. Nephrol Dial Transpl 17 : 112 117, 2002
80. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT : Hemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis: analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 14 : 2851 2860, 2003
81. Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, et al. : Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 143 : 174 183, 2005
82. Lo WK, Lui SL, Chan TM, Li K, Lam MF, Tse KC, Tang SCW, Choy CBY, Lai KN : Minimal and optimal peritoneal Kt/V targets - results of an anuric peritoneal dialysis patients survival analysis. Kidney Int 67 : 2032 2038, 2005
83. Jansen MAM, Termorshuizen F, Korevaar JC, Dekker FW, Boeschoten E, Krediet RT : Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 68 : 1199 1205, 2005
84. Szeto CC, Wong TYH, Chow KM, Leung CB, Law MC, Wang AYM, Lui SF, Li PKT : Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 12 : 355 360, 2001
85. Brown EA, Davies SJ, Rutherford P, et al. : Survival of functionally anuric patients on automated peritoneal dialysis: The European APD Outcome Study. J Am Soc Nephrol 14 : 2948 2957, 2003
86. Locatelli F, Marcelli D, Conte F, Limido A, Malberti A, Spotti D : Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisis E Trapianto. Kidney Int 55 : 286 293, 1999
87. Kim DJ, Do JH, Huh WS, et al. : Dissociation between clearances of small and middle molecules in incremental peritoneal dialysis. Perit Dial Int 21 : 462 466, 2001
88. Araujo T, Maria R, Pecoits-Filho RF, Romao JE Jr., Sabbaga E, Marcondes MM, Abensur H : The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test. Perit Dial Int 22 : 229 233, 2002
89. Demetriou D, Habicht A, Schillinger M, Horl WH, Vychytil A : Adequacy of automated peritoneal dialysis with and without manual daytime exchange: a randomized controlled trial. Kidney Int 70 : 1649 1655, 2006
90. Finkelstein F, Healy H, Abu0alfa A, Ahmad S, Brown F, Gehr T, Nash K, Sorkin M, Mujais S : Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 16 : 546 554, 2005
91. Lo WK, Cheng SW, Lo CY, Li FK, Chan TM, Cheng IKP : Patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) with a basic three liters daily exchanges - a twelve years single center experience in the pre-urea kinetics era. Hong Kong J Nephrol 1 : 35 40, 1999
92. Khanna G, Nolph K (eds The Textbook of Peritoneal Dialysis, 2nd edn. Dordrecht : Kluwer Academic Publishers, 2000
93. De Vriese As, Mortier S, Lameire NH : What happens to the peritoneal membrane in long-term peritoneal dialysis? Perit Dial Int 21 (Suppl. 3 S9 S18, 2001
94. Selgas R, Fernández-Reyes MJ, Bosque E, et al. : Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 23 : 64 73, 1994
95. Selgas R, Bajo MA, Del Peso G, et al. : Preserving the peritoneal dialysis membrane in long-term peritoneal dialysis patients. Semin Dial 8 : 326 332, 1995
96. Selgas R, Bajo MA, Paiva A, et al. : Stability of the peritoneal membrane in long-term peritoneal dialysis patients. Adv Ren Replac Ther 5 : 168 178, 1998
97. Krediet R : The peritoneal membrane in chronic peritoneal dialysis patients. Kidney Int 55 : 341 356, 1999
98. Smit W, Van Dijk P, Lagedijk MJ, et al. : Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 23 : 440 449, 2003
99. Davies SJ, Phillips L, Russell GI : Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 13 : 962 968, 1998
100. Churchill DN, Thorpe KE, Nolph KD, et al. CANUSA Study group : Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 9 : 1285 1292, 1998
101. Díaz-Buxo JA, Lowrie EG, Lew NL, et al. : Associates of mortality among peritoneal dialysis patients with special references to peritoneal transport rates and solute clearance. Am J Kidney Dis 33 : 523 534, 1999
102. Ates K, Nergizoglu K, Keven K, et al. : Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 60 : 767 776, 2001
103. Garosi G, Di Paolo N : Peritoneal sclerosis - an overview. Adv Perit Dial 15 : 185 192, 1999
104. Krediet RT, Lindholm B, Rippe B : Pathophysiology of peritoneal membrane failure. Perit Dial Int 20 (Suppl. 4 S22 S42, 2000
105. Combet S, Miyata T, Moulin P, et al. : Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 11 : 717 728, 2000
106. Selgas R, Del Peso G, Bajo MA, et al. : Spontaneous VEGF production by cultured peritoneal mesothelial cells from patients on peritoneal dialysis. Perit Dial Int 20 : 798 801, 2000
107. Selgas R, del Peso G, Bajo MA, et al. : Vascular endothelial growth factor (VEGF) levels in peritoneal dialysis effluent. J Nephrol 14 : 270 274, 2001
108. Margetts PJ, Bonniaud P : Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 23 : 530 541, 2003
109. De Vriese AS, Tilton RG, Mortier S, Lameire NH : Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant 21 : 2549 2555, 2006
110. Mateijsen MAM, van der Wal AC, Hendriks PMEM, et al. : Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19 : 517 525, 1999
111. Plum J, Hermann S, Fussholler A, et al. : Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int 78 (Suppl. S42 S47, 2001
112. Williams JD, Craig KJ, Topley N, et al. : Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13 : 470 479, 2002
113. Bertoli SV, Buzzi L, Ciurlino D : Morphofunctional study of peritoneum in peritoneal dialysis patients. J Nephrol 16 : 373 378, 2003
114. Krediet RT, Zweers MM, van der Wal AC, Struijk DG : Neoangiogenesis in the peritoneal membrane. Perit Dial Int 20 (Suppl. 2 S19 S25, 1999
115. Del Peso G, Jiménez-Heffernan JA, Bajo MA, Aroeira LS, Aguilera A, Fernández-Perpén A, Cirujeda A, Castro MJ, De Gracia R, Sánchez-Villanueva R, Sánchez-Tomero JA, López-Cabrera M, Selgas R : Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport. Kidney Int (in press)
116. Yáñez-Mó M, Lara-Pezzi E, Selgas R, et al. : Peritoneal dialysis induces an epithelial-mesenchymal transition of mesothelial cells. N Engl J Med 348 : 403 413, 2003
117. Yang AH, Chen JY, Lin JK : Myofibroblastic conversion of mesothelial cells. Kidney Int 63 : 1530 1539, 2003
118. Sherif AM, Nakayama M, Maruyama Y, et al. : Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients. Nephrol Dial Transplant 21 : 1675 1678, 2006
119. Margetts P, Kolb M, Galt T, et al. : Gene transfer of transforming growth factor-β1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 12 : 2029 2039, 2001
120. Margetts PJ, Bonniaud P, Liu L, et al. : Transient overexpression of TGF-β1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 16 : 425 436, 2005
121. De Vriese AS, Tilton RG, Stephan CC, et al. : Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 12 : 1734 1741, 2001
122. Mandl-Weber S, Cohen CD, Haslinger B, et al. : Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 61 : 570 578, 2002
123. Rodrigues A, Martins M, Santos MJ : Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport. Adv Perit Dial 20 : 8 12, 2004
124. Aroeira LS, Aguilera A, Selgas R, et al. : Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 46 : 938 948, 2005
125. Pecoits-Filho R, Araujo MR, Lindholm B, et al. : Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 17 : 1480 1486, 2002
126. Zweers MM, de Waart DR, Smit W, et al. : Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med 134 : 124 132, 1999
127. Mujais S, Story K : Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts. Kidney Int 70 (Suppl. 103 S21 S26, 2006
128. Ganesh SK, et al. : Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 14 : 415 424, 2003
129. Stack AG, et al. : Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 64 : 1071 1079, 2003
130. Vonesh EF, et al. : The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 66 : 2389 2401, 2004
131. Trespalacios FC, et al. : Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis 41 : 1267 1277, 2003
132. Bleyer AJ, Russell GB, Satko SG : Sudden and cardiac death rates in hemodialysis patients. Kidney Int 55 : 1553 1559, 1999
133. Mujais S, Vonesh E : Profiling of peritoneal ultrafiltration. Kidney Int 62 (Suppl. 81 S17 S22, 2002
134. Gunal AI, et al. : Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 37 : 588 593, 2001
135. Abu-Alfa AK, et al. : Approach to fluid management in peritoneal dialysis: a practical algorithm. Kidney Int 70 (Suppl. 81 S8 S16, 2002
136. Holmes C, Mujais S : Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int 70 (Suppl. 103 S104 S109, 2006
137. Verger C, et al. : French peritoneal dialysis registry (RDPLF): outline and main results. Kidney Int 70 (Suppl. 103 S12 S20, 2006
138. Johnson DW, et al. : Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrol 2 : 2, 2001
139. Mujais S, Childers RW : Profiles of automated peritoneal dialysis prescriptions in the US 1997-2003. Kidney Int 70 (Suppl. 103 S84 S90, 2006
140. Krediet R, Mujais S : Use of icodextrin in high transport ultrafiltration failure. Kidney Int 62 (Suppl. 81 53 61, 2002
141. Mujais S : Ultrafiltration management in automated peritoneal dialysis. Contrib Nephrol 129 : 255 266, 1999
142. Mujais S, et al. : Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 20 (Suppl. 4 S5 S21, 2000
143. Davies SJ, et al. : Integrated care. Perit Dial Int 21 (Suppl. 3 S269 S274, 2001
144. Mendelssohn DC, Pierratos A : Reformulating the integrated care concept for the new millennium. Perit Dial Int 22 : 5 8, 2002
145. Van Biesen W, et al. : An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 11 : 116 125, 2000